Thanks for the correction on Anakinra being an IL-1 antagonist not an antibody, still that doesn't change my point about the two trials design and size.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.